The expected Q4 loss and revenue decline indicate potential short-term negative impact on RXT's stock price. However, the recent board appointment and the mixed analyst ratings, especially the positive adjustment from BMO Capital, could provide some counterbalance. The overall negative outlook from analysts, with Citigroup and Barclays projecting lower price targets, suggests a bearish sentiment that could influence investor perception and stock performance in the short term.